Nano-X Imaging (NNOX) Current Deferred Revenue (2021 - 2026)

Nano-X Imaging (NNOX) has reported Current Deferred Revenue for 6 consecutive years, with $454000.0 the latest figure, recorded in Q1 2026.

• Quarterly Current Deferred Revenue rose 305.36% year-over-year to $454000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $454000.0 (up 305.36% YoY) and the FY2025 annual result came in at $534000.0, up 281.43% from the prior year.
• Current Deferred Revenue eased to $454000.0 in Q1 2026 per NNOX's latest filing, from $534000.0 in the prior quarter.
• Over the last five years, Current Deferred Revenue for NNOX reached as high as $626.0 million in Q3 2022 and fell as low as $112000.0 in Q1 2025.
• A 5-year average of $71.3 million and a median of $517000.0 in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue slumped 99.92% — and 2026, when it surged 305.36%.
• Year by year, Current Deferred Revenue stood at $580000.0 in 2022, then fell by 6.38% to $543000.0 in 2023, then tumbled by 74.22% to $140000.0 in 2024, then soared by 281.43% to $534000.0 in 2025, then declined by 14.98% to $454000.0 in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $454000.0, $534000.0, and $273000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.